INTERNATIONAL PATENT: ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD., 浙江扬厉医药技术有限公司 FILES APPLICATION FOR "THIAZOLE SUBSTITUTED PYRIMIDINAMINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF"

GENEVA, Nov. 24 -- ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room 1106, Building 1, Haozhang Plaza, Gongshu DistrictHangzhou, Zhejiang 310024), 浙江扬厉医药技术有限公司 (中国浙江省杭州市拱墅区皓章大厦1幢1106室) filed a patent application (PCT/CN2025/094883) for "THIAZOLE SUBSTITUTED PYRIMIDINAMINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF" on May 14, 2025. With publication no. WO/2025/237337, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Pa...